Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes

Journal of Clinical Oncology

Volumn 29, Issue 21, 2011, Pages 2897-2903

  Kristinsson, Sigurdur Y ^a   Björkholm, Magnus ^a   Hultcrantz, Malin ^a   Derolf, Åsa R ^a   Landgren, Ola ^a,b   Goldin, Lynn R ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; HUMAN; IMMUNOSTIMULATION; INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MYELODYSPLASTIC SYNDROME; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; COMMUNICABLE DISEASES; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; LOGISTIC MODELS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; ODDS RATIO; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SWEDEN; TIME FACTORS;

EID: 79960709287     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.34.8540     Document Type: Article

References (31)

1. Estey E, Döhner H: Acute myeloid leukemia. Lancet 368:1894-1907, 2006
2. Derolf AR, Kristinsson SY, Andersson TM, et al: Improved patient survival for acute myeloid leukemia: A population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005. Blood 113:3666-3672, 2009
3. Swerdlow SH, Campo E, Harris NL, et al: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed 4), Lyon, France, International Agency for Research on Cancer, 2008
4. Travis LB, Li CY, Zhang ZN, et al: Hematopoietic malignancies and related disorders among benzene-exposed workers in China. Leuk Lymphoma 14:91-102, 1994 (Pubitemid 24197029)
5. Kane EV, Roman E, Cartwright R, et al: Tobacco and the risk of acute leukaemia in adults. Br J Cancer 81:1228-1233, 1999
6. Strom SS, Gu Y, Gruschkus SK, Pierce SA, et al: Risk factors of myelodysplastic syndromes: A case-control study. Leukemia 19:1912-1918, 2005
7. Smith SM, Le Beau MM, Huo D, et al: Clinicalcytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: The University of Chicago series. Blood 102:43-52, 2003
8. Pedersen-Bjergaard J, Andersen MK, Andersen MT, et al: Genetics of therapy-related myelodysplasia and acute myeloid leukemia. Leukemia 22:240-248, 2008 (Pubitemid 351250527)
9. Malinge S, Izraeli S, Crispino JD: Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome. Blood 113:2619-2628, 2009
10. Cervantes F, Tassies D, Salgado C, et al: Acute transformation in nonleukemic chronic myeloproliferative disorders: Actuarial probability and main characteristics in a series of 218 patients. Acta Haematol 85:124-127, 1991
11. Abdulkarim K, Girodon F, Johansson P, et al: AML transformation in 56 patients with Ph- MPD in two well defined populations. Eur J Haematol 82:106-111, 2009
12. Cooper GS, Kamel F, Sandler DP, et al: Risk of adult acute leukemia in relation to prior immunerelated conditions. Cancer Epidemiol Biomarkers Prev 5:867-872, 1996 (Pubitemid 26382979)
13. Zheng W, Linet MS, Shu XO, et al: Prior medical conditions and the risk of adult leukemia in Shanghai, People's Republic of China. Cancer Causes Control 4:361-368, 1993 (Pubitemid 23205747)
14. Kristinsson SY, Landgren O, Samuelsson J, et al: Autoimmunity and the risk of myeloproliferative neoplasms. Haematologica 95:1216-1220, 2010
15. Socialstyrelsen: Cancer Incidence in Sweden 2006. Stockholm, Sweden, The National Board of Health and Welfare, 2007
16. Turesson I, Linet MS, Björkholm M, et al: Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003. Int J Cancer 121:2260-2266, 2007
17. Koshiol J, Gridley G, Engels EA, et al: Chronic immune stimulation and subsequent Waldenstrom macroglobulinemia. Arch Intern Med 168:1903-1909, 2008
18. Linet MS, Humphrey RL, Mehl ES, et al: A case-control and family study of Waldenstrom's macroglobulinemia. Leukemia 7:1363-1369, 1993 (Pubitemid 23291076)
19. Smedby KE, Hjalgrim H, Askling J, et al: Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 98:51-60, 2006 (Pubitemid 43057092)
20. Landgren O, Engels EA, Pfeiffer RM, et al: Autoimmunity and susceptibility to Hodgkin lymphoma: A population-based case-control study in Scandinavia. J Natl Cancer Inst 98:1321-1330, 2006 (Pubitemid 44530727)
21. Bowen DT: Etiology of acute myeloid leukemia in the elderly. Semin Hematol 43:82-88, 2006
22. Deschler B, Lübbert M: Acute myeloid leukemia: Epidemiology and etiology. Cancer 107:2099-2107, 2006 (Pubitemid 44665642)
23. Kristinsson SY, Koshiol J, Bjorkholm M, et al: Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia. J Natl Cancer Inst 102:557-567, 2010
24. Landgren O, Rapkin JS, Caporaso NE, et al: Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia. Blood 109:2198-2201, 2007 (Pubitemid 46348222)
25. Anderson LA, Pfeiffer RM, Landgren O, et al: Risks of myeloid malignancies in patients with autoimmune conditions. Br J Cancer 100:822-828, 2009
26. Socié G, Henry-Amar M, Bacigalupo A, et al: Malignant tumors occurring after treatment of aplastic anemia: European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med 329:1152-1157, 1993
27. Söderberg KC, Jonsson F, Winqvist O, et al: Autoimmune diseases, asthma and risk of haematological malignancies: A nationwide case-control study in Sweden. Eur J Cancer 42:3028-3033, 2006 (Pubitemid 44667472)
28. Askling J, Fored CM, Baecklund E, et al: Haematopoietic malignancies in rheumatoid arthritis: Lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis 64:1414-1420, 2005 (Pubitemid 41623850)
29. Dalamaga M, Petridou E, Cook FE, et al: Risk factors for myelodysplastic syndromes: A casecontrol study in Greece. Cancer Causes Control 13:603-608, 2002 (Pubitemid 35001767)
30. Enright H, Miller W: Autoimmune phenomena in patients with myelodysplastic syndromes. Leuk Lymphoma 24:483-489, 1997 (Pubitemid 27182203)
31. Kolte B, Baer AN, Sait SN, et al: Acute myeloid leukemia in the setting of low dose weekly methotrexate therapy for rheumatoid arthritis. Leuk Lymphoma 42:371-378, 2001 (Pubitemid 32725592)